Chronic Inflammation in Obesity and Cancer Cachexia.
Rosa DivellaGennaro Gadaleta CaldarolaAntonio MazzoccaPublished in: Journal of clinical medicine (2022)
Chronic inflammation has long been linked to obesity and related conditions such as type 2 diabetes and metabolic syndrome. According to current research, the increased risk of cancer in people with certain metabolic diseases may be due to chronic inflammation. Adipocytokines, which are pro-inflammatory cytokines secreted in excess, are elevated in many chronic metabolic diseases. Cytokines and inflammatory mediators, which are not directly linked to DNA, are important in tumorigenesis. Cachexia, a type of metabolic syndrome linked to the disease, is associated with a dysregulation of metabolic pathways. Obesity and cachexia have distinct metabolic characteristics, such as insulin resistance, increased lipolysis, elevated free fatty acids (FFA), and ceramide levels, which are discussed in this section. The goal of this research project is to create a framework for bringing together our knowledge of inflammation-mediated insulin resistance.
Keyphrases
- insulin resistance
- metabolic syndrome
- type diabetes
- oxidative stress
- adipose tissue
- high fat diet induced
- high fat diet
- polycystic ovary syndrome
- skeletal muscle
- uric acid
- papillary thyroid
- fatty acid
- cardiovascular risk factors
- squamous cell
- glycemic control
- single molecule
- drug induced
- weight gain
- cell free
- lymph node metastasis